Butterfly Network, Inc.

BFLY • Medical - Devices

$7.36

▲ +0.07 (+0.96%)

Precio actual

ResultadosÚltimo reporte: 30 jun 2026

PERFIL DÉBILDébilConfianza: 70%

Perfil cuantitativo — no constituye una recomendación de inversión.

Perfil cuantitativo — no constituye una recomendación de inversión.Metodología

Tesis del análisis: Perfil histórico débil. La evidencia actual no sostiene una relación riesgo/retorno favorable.

Capitalización

$1.93B

Crecimiento

4.5%

Flujo de caja

0/5

Tendencia

Negative

Evidencia

Nivel de deuda manejable · 0.1Liquidez saludable · 3.83Rentabilidad débil

Datos financieros hasta: 30 jun 2026, 12:00 a.m. UTCÚltima actualización de earnings: 30 jun 2026, 12:00 a.m. UTCÚltima actualización del perfil: 5 ago 2026, 2:27 p.m. UTC

Resumen de la compañía

Valoración, calidad, fortaleza financiera, momentum y datos de analistas.

Price$7.36

Change0.96%

Shares Out262.10M

Market Cap$1.93B

Enterprise Value$1.82B

52W Range1.32 - 9.69

Beta2.05

P/E-25.77

P/S17.77

P/B10.19

P/FCF-53.89

EV/Sales16.77

Price$7.36

Change0.96%

Shares Out262.10M

Market Cap$1.93B

Enterprise Value$1.82B

52W Range1.32 - 9.69

Beta2.05

P/E-25.77

P/S17.77

P/B10.19

P/FCF-53.89

EV/Sales16.77

EV/EBITDA-25.97

EV/FCF-50.87

Earnings Yield-3.88%

FCF Yield-1.86%

Dividend Yield0.00%

Gross Margin46.85%

Oper. Margin-88.53%

Profit Margin-78.95%

Debt/Eq0.10

Current Ratio3.83

Quick Ratio2.88

Revenue 5Y4.53%

Target$5.19

Target Upside-29.48%

Target Median$5.38

Target Range4.50 - 5.50

Volume10.87M

Avg Volume7.93M

EPS Surprise0.01

ADN de inversión

Qué tan fuerte luce esta compañía para inversionistas de largo plazo

de 100

Calidad del negocio

Márgenes, ventaja competitiva, retornos

22/100

Fortaleza financiera

Deuda, caja, estabilidad

76/100

Potencial de crecimiento

Ingresos y expansión

43/100

Atractivo del precio

Barata o cara hoy

43/100

Por qué este puntaje▼

Nivel de deuda manejable · 0.1Liquidez saludable · 3.83Rentabilidad débil

Analyst view

Analyst sentiment and price target

BFLY

Analyst sentiment

Based on 7 analyst votes · 2026-09-05

93/100

Bullish

Hold

Bearish

Precio objetivo

2026-08-02

Bajo

$5.50

Promedio

$5.50

Mediana

$5.50

Alto

$5.50

Resumen de la compañía

IPO: 7/13/2020

Industria: Medical - Devices

P/B i: 10.19

Deuda / Patrimonio i: 0.10

Margen operativo: -88.53%

Margen neto: -78.95%

ROE i: -

ROIC: -

Salud financiera

Puntaje15 / 20

Deuda / Patrimonio: 0.10

Ratio corriente: 3.83

Ratio rápido: 2.88

Estado: Good

Transacciones internas

Actividad reciente de ejecutivos e insiders

⚠ 9 venta interna de alto volumens detectadas

ROTHBERG JONATHAN M

Transacción: 07/22/2026

VENTA

Cambio

-36,366

Precio

$6.47

Presentación

07/24/2026

Tipo

VENTA

ROTHBERG JONATHAN M

Transacción: 07/21/2026

VENTA

Cambio

-753,320

Precio

$6.74

Presentación

07/21/2026

Tipo

VENTA

DEVIVO JOSEPH

Transacción: 07/20/2026

VENTA

Cambio

-211,798

Precio

$6.56

Presentación

07/21/2026

Tipo

VENTA

Insider	Tipo	Cambio	Precio	Transacción	Presentación
ROTHBERG JONATHAN M	VENTA	-36,366	$6.47	07/22/2026	07/24/2026
ROTHBERG JONATHAN M	VENTA	-753,320	$6.74	07/21/2026	07/21/2026
DEVIVO JOSEPH	VENTA	-211,798	$6.56	07/20/2026	07/21/2026
Doherty John N.	VENTA	-57,136	$6.56	07/20/2026	07/21/2026
Ku Victor	VENTA	-48,540	$6.56	07/20/2026	07/21/2026
ROTHBERG JONATHAN M	VENTA	-1,177,276	$6.61	07/20/2026	07/21/2026
ROTHBERG JONATHAN M	VENTA	-1,195,857	$6.60	07/17/2026	07/21/2026
ROTHBERG JONATHAN M	VENTA	-1,213,634	$7.09	07/16/2026	07/16/2026
ROTHBERG JONATHAN M	VENTA	-253,867	$7.09	07/16/2026	07/16/2026
ROTHBERG JONATHAN M	VENTA	-1,730,319	$7.32	07/15/2026	07/16/2026
ROTHBERG JONATHAN M	VENTA	-815,632	$7.72	07/14/2026	07/16/2026
DEVIVO JOSEPH	VENTA	-204,725	$7.87	07/07/2026	07/08/2026
Doherty John N.	VENTA	-55,229	$7.87	07/07/2026	07/08/2026
Ku Victor	VENTA	-35,649	$7.87	07/07/2026	07/08/2026
Carlson Megan	VENTA	-41,303	$7.96	07/02/2026	07/07/2026
Edelman Elazer R	COMPRA	+25,447	Not reported	06/22/2026	06/22/2026
Neubauer Caroll H	COMPRA	+25,447	Not reported	06/22/2026	06/22/2026
Phanstiel S. Louise	COMPRA	+25,447	Not reported	06/22/2026	06/22/2026
ROBBINS LARRY	COMPRA	+25,447	Not reported	06/22/2026	06/22/2026
ROTHBERG JONATHAN M	COMPRA	+25,447	Not reported	06/22/2026	06/22/2026

Sobre la compañía

Butterfly Network, Inc.

Butterfly Network, Inc. functions as a digital health enterprise, specializing in the invention, production, and global commercialization of cutting-edge ultrasound imaging technologies for both domestic and international markets. The company's innovative product portfolio includes the portable Butterfly iQ, a versatile single-probe system capable of whole-body ultrasound imaging, and the Butterfly iQ+, a point-of-care ultrasound device engineered to connect effortlessly with smartphones, tablets, and existing hospital computer networks. Additionally, Butterfly Blueprint is offered as a comprehensive, system-wide ultrasound platform that seamlessly integrates its proprietary Compass software into a healthcare provider's clinical and administrative infrastructure. These ultrasound systems, encompassing probes, related accessories, and software subscriptions, are supplied to healthcare systems, individual physicians, and other medical professionals through a multi-channel distribution strategy that includes a direct sales force, a network of distributors, and an e-commerce platform. Beyond its hardware, Butterfly Network provides a suite of cloud-based software solutions for healthcare organizations. These offerings feature teleguidance services, interactive in-app educational modules, and structured training programs delivered via its Butterfly Academy software, all complemented by dedicated clinical support and services. Established in 2011, Butterfly Network, Inc. has its corporate headquarters situated in Guilford, Connecticut.

Fuente - Link

Competidores

AMN ARVN ATXS DAWN EVH FLGT OFIX PACB SIBN VALN

Tamaño = capitalización · color = línea del gráfico

Rendimiento de peers · 1A

Top performers + empresa seleccionada

Ultimas Noticias

Merge Labs and Butterfly Network Partner to Advance Ultrasound-Based Brain-Computer Interfaces

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)---- $BFLY #POCUS--Butterfly Network, Inc. ("Butterfly") (NYSE: BFLY), a pioneer and leader in semiconductor-based ultrasound, programmable cloud software and AI, and Merge Labs today announced a multi-year licensing agreement through Butterfly Embedded™. The agreement gives Merge access to Butterfly's Poseidon Family of Ultrasound-on-Chip™ technology for the development of ultrasound-based brain-computer interfaces (BCI). Merge Labs was founded with the long-term mi.

Business Wire

Butterfly Network Director Phanstiel Buys $1.0 Million in Stock. Is This a Sign Investors Should Also Buy?

Louise S. Phanstiel acquired ~115,000 shares at $8.68 per share, representing a total transaction value of $1.0 million. The purchase increased the director's total equity holdings by 20% and indirect holdings by 62%.

The Motley Fool

Butterfly Network CEO Joseph Devivo Sells 68,346 Shares

68,346 shares were sold for ~$684,143 on August 10, 2026. The transaction represents a 0.89% reduction in direct equity holdings.

The Motley Fool

Butterfly Network's Co-Founder Wanted To Change The World, And He Is

Butterfly Network (BFLY) traces back to a not-so-modest aspiration of one co-founder, to change the world, and a fortunate introduction by his professor to a visionary tech entrepreneur. BFLY is doing that through its pioneering ultrasound on a chip. A scanner sends images to an iPhone or similar device. That makes ultrasound doable pretty much anywhere. That's a huge deal. Cumbersome logistics cause many to refrain from being scanned as regularly as they should, often to bad and sometimes tragic results.

Seeking Alpha

Butterfly Network Congratulates Dr. Erica Schwartz on Confirmation as CDC Director

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)---- $BFLY #POCUS--Butterfly Network, Inc. ("Butterfly") (NYSE: BFLY), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, congratulates Dr. Erica Schwartz on her confirmation as director of the Centers for Disease Control and Prevention (CDC). Dr. Schwartz has served as a member of Butterfly Network's Board of Directors since 2021 and has stepped down from the Board effective August 5, 2026 in advance of assuming her n.

Business Wire

Sorpresas de ganancias

Período	Estimado	Real	Sorpresa
2026-04-30	-0.04	-0.03	0.01
2026-02-26	-0.04	-0.02	0.02
2025-10-31	-0.07	-0.13	-0.06
2025-08-01	-0.07	-0.06	0.01
2025-05-02	-0.09	-0.06	0.03
2025-02-28	-0.09	-0.08	0.01
2024-11-01	-0.1	-0.08	0.02
2024-08-01	-0.1	-0.05	0.05
2024-05-01	-0.12	-0.07	0.05
2024-02-28	-0.12	-0.21	-0.09
2023-11-02	-0.15	-0.13	0.02
2023-08-03	-0.17	-0.14	0.03